New Cell Cycle Inhibitors Eradicate Aneuploid Cancers
Yale Cancer Center via YouTube
-
28
-
- Write review
Lead AI Strategy with UCSB's Agentic AI Program — Microsoft Certified
Launch Your Cybersecurity Career in 6 Months
Overview
Google, IBM & Meta Certificates — All 10,000+ Courses at 40% Off
One annual plan covers every course and certificate on Coursera. 40% off for a limited time.
Get Full Access
Explore groundbreaking research on novel cell cycle inhibitors and their potential to eliminate aneuploid cancers in this 57-minute grand rounds presentation from Yale Cancer Center. Learn about cutting-edge therapeutic approaches that target the unique vulnerabilities of cancer cells with abnormal chromosome numbers, examining how these new inhibitors work at the molecular level to selectively destroy aneuploid tumor cells while sparing normal diploid cells. Discover the latest clinical and preclinical data demonstrating the efficacy of these targeted treatments, understand the mechanisms underlying aneuploidy in cancer development and progression, and gain insights into how this research is translating into promising new treatment strategies for patients with various types of cancer characterized by chromosomal instability.
Syllabus
New Cell Cycle InhibitorsEradicate Aneuploid Cancers
Taught by
Yale Cancer Center
Reviews
3.0 rating, based on 1 Class Central review
Showing Class Central Sort
-
I get a brief knowledge on cancer cells in this course. I want to get certificates in this course. This is highly informative that based on cancer cells, cancer causes, gene mutations, cancer causes due to mutations in gene, chromosomes etc.